Trial intelligence / Profile preview

Real-world multicenter registry of Cistanche Yizhi Capsule for vascular dementia

ChiCTR2100053281Phase 4Recruiting

Sponsor
Xiyuan Hospital
Start
Dec 2021
Countries
1
01

Overview

Phase 4, open-label trial of fufang congrong yizhi in vascular dementia (2 arms), sponsored by Xiyuan Hospital. Primary endpoint: Vascular dementia assessment scale - cognitive subscale. Started Dec 2021; status: recruiting.

02

Drugs

fufang congrong yizhi
03

Conditions

vascular dementia

Beyond the preview

Go deeper on ChiCTR2100053281.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100053281.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call